Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16466750
[patent_doc_number] => 20200368287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/902414
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902414 | Platform for generating safe cell therapeutics | Jun 15, 2020 | Issued |
Array
(
[id] => 16613949
[patent_doc_number] => 20210032602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => EX VIVO PROLIFERATION OF EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/899989
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899989 | Ex vivo proliferation of epithelial cells | Jun 11, 2020 | Issued |
Array
(
[id] => 16450183
[patent_doc_number] => 20200359609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS RELATING TO COMPLEMENT DEPENDENT CYTOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 16/886289
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886289 | Genetically modified non-human animals and methods relating to complement dependent cytotoxicity | May 27, 2020 | Issued |
Array
(
[id] => 16312666
[patent_doc_number] => 20200291404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => RNA HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 16/882812
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16882812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/882812 | RNA HYDROGELS | May 25, 2020 | Abandoned |
Array
(
[id] => 16267371
[patent_doc_number] => 20200268858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => GLAUCOMA TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/869799
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869799 | Glaucoma treatment | May 7, 2020 | Issued |
Array
(
[id] => 19058997
[patent_doc_number] => 11938191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Block copolymers
[patent_app_type] => utility
[patent_app_number] => 16/864613
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 20
[patent_no_of_words] => 52062
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864613 | Block copolymers | Apr 30, 2020 | Issued |
Array
(
[id] => 16341667
[patent_doc_number] => 20200306317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS OF PREPARING AND USING NOVEL STEM CELL COMPOSITIONS AND KITS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/859790
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859790 | Methods of preparing and using novel stem cell compositions and kits comprising the same | Apr 26, 2020 | Issued |
Array
(
[id] => 16709500
[patent_doc_number] => 20210076647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES
[patent_app_type] => utility
[patent_app_number] => 16/855905
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855905 | Double knockout (GT/CMAH-KO) pigs, organs and tissues | Apr 21, 2020 | Issued |
Array
(
[id] => 16204690
[patent_doc_number] => 20200237680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NANOFIBER SCAFFOLDS FOR BIOLOGICAL STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 16/845719
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845719 | Nanofiber scaffolds for biological structures | Apr 9, 2020 | Issued |
Array
(
[id] => 16221335
[patent_doc_number] => 20200246451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PRODUCING RNA COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/838746
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838746 | Method for producing RNA compositions | Apr 1, 2020 | Issued |
Array
(
[id] => 19456799
[patent_doc_number] => 12097268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Modulation of neural pathways
[patent_app_type] => utility
[patent_app_number] => 16/823905
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26661
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823905 | MODULATION OF NEURAL PATHWAYS | Mar 18, 2020 | Pending |
Array
(
[id] => 16506465
[patent_doc_number] => 20200385721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/819766
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819766 | DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES | Mar 15, 2020 | Pending |
Array
(
[id] => 17378136
[patent_doc_number] => 11236133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Chimeric receptor binding proteins for use in bacterial delivery vehicles
[patent_app_type] => utility
[patent_app_number] => 16/816675
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31234
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/816675 | Chimeric receptor binding proteins for use in bacterial delivery vehicles | Mar 11, 2020 | Issued |
Array
(
[id] => 17805843
[patent_doc_number] => 20220257678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS (RAAV) HAVING IMPROVED PACKAGING EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/627165
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627165 | RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS (RAAV) HAVING IMPROVED PACKAGING EFFICIENCY | Mar 11, 2020 | Pending |
Array
(
[id] => 16282664
[patent_doc_number] => 20200276266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => SRPX FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/815356
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/815356 | SRPX for treatment of cancer | Mar 10, 2020 | Issued |
Array
(
[id] => 16153481
[patent_doc_number] => 20200214973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Microbubble Nucleic Acid Delivery Platform
[patent_app_type] => utility
[patent_app_number] => 16/808984
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808984 | Microbubble nucleic acid delivery platform | Mar 3, 2020 | Issued |
Array
(
[id] => 16583137
[patent_doc_number] => 20210017539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Genome Editing without Nucleases
[patent_app_type] => utility
[patent_app_number] => 16/801531
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801531
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801531 | Genome Editing without Nucleases | Feb 25, 2020 | Abandoned |
Array
(
[id] => 16523632
[patent_doc_number] => 20200397712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES
[patent_app_type] => utility
[patent_app_number] => 16/799536
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799536 | NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES | Feb 23, 2020 | Abandoned |
Array
(
[id] => 16376702
[patent_doc_number] => 20200325544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES
[patent_app_type] => utility
[patent_app_number] => 16/798140
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798140 | METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES | Feb 20, 2020 | Abandoned |
Array
(
[id] => 15990477
[patent_doc_number] => 20200171109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHOD FOR INDUCING PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR
[patent_app_type] => utility
[patent_app_number] => 16/783717
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783717 | Method for inducing production of vascular endothelial growth factor | Feb 5, 2020 | Issued |